Tech Company Financing Transactions
Melinta Therapeutics Funding Round
Private investors invested in a $5.5 million capital raise for Melinta Therapeutics. This venture round was announced on 1/28/2011.
Transaction Overview
Company Name
Announced On
1/28/2011
Transaction Type
Debt
Amount
$5,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. Amount included options, warrants or other rights to acquire another security. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
300 George St. 301
New Haven, CT 06511
USA
New Haven, CT 06511
USA
Phone
Website
Email Address
Overview
Melinta Therapeutics' mission is to discover, develop and commercialize groundbreaking antibiotics to overcome drug-resistant, life-threatening infections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christine Miller
Chief Financial Officer
Peter Milligan
VP - Bus. Development
Michael McGuire
VP - Finance
Susan Blum
VP - General Counsel
Jennifer Sanfilippo
Browse more venture capital transactions:
Prev: 1/27/2011: Plum District venture capital transaction
Next: 1/28/2011: UsingMiles venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs